Elite Multi-Mode Stimulator

Key Features

  • Dual Therapy Channels
  • True Interferential Therapy Output
  • Neuromuscular Therapy Output
  • Symmetrical biphasic square wave with zero net DC component
  • Uses 2 Common AA Batteries
  • 14 Preset Therapy Protocols (10 Interferential Stimulation, 4 Muscle Stimulation)
  • 0-45 milliamps, adjustable
  • 1 – 150 Hz Net Interferential Frequency


Elite Multi-Mode Stimulator

The Multi-Mode Stimulator is a high-quality, advanced technology medical device designed to be used as a combination interferential and muscle stimulator. The Multi-Mode Stimulator is battery powered using standard AA batteries. Current is generated and controlled by circuitry using Texas Instruments® microprocessor chips. These chips provide the Multi-Mode Stimulator with the greatest degree of control and intelligence on the market today. The Multi-Mode Stimulator was designed for the homecare market and many of the Multi-Mode Stimulator features are the result of countless discussions with patients, physicians and therapists as to what they want and need in a clinic and home use therapy device.

Interferential Current Mode

  • Relieves symptoms of chronic pain
  • Serves as an adjunct treatment to manage surgical and post-traumatic pain

Neuromuscular Stimulator Mode

  • Relaxes muscle spasms
  • Increases local blood circulation
  • Maintains and increases range of motion
  • Prevents or retards:
    • Disuse atrophy
    • Muscle re-education
    • Immediate post-surgical stimulation of calf muscles
  • Prevents venous thrombosis

Typical Indications

Interferential Current Mode: Symptomatic relief and management of chronic pain and/or as an adjunctive treatment for the management of post-surgical and post-traumatic pain.

Neuromuscular Stimulator Mode: Relaxation of muscle spasm, increasing local blood circulation, maintaining and increasing range of motion, preventing or retarding disuse atrophy, muscle re-education, and immediate post-surgical stimulation of calf muscles to prevent venous thrombosis.

  • A 2004 multi-center clinical trial assessed IFT as an adjunct to manipulative therapy for acute low back pain. At 12 months follow-up overall measures of physical function and bodily pain showed a statistically significant trend favoring combined therapy (average 90% greater improvement with IFT added, P=0.04, Spine;29: 2207-2216).
  • A 2010 meta-analysis assessing the efficacy of IFT for both acute and chronic musculoskeletal conditions found evidence supporting its pain relieving effect versus placebo (Phys Ther. Vol 90(9): p1219-1238).
  • A 2011 paper on chronic low back pain, found significant reductions in pain and disability scores, and much higher percentages of stopped pain medication in the IFT treatment group versus controls (Sao Paulo Med J; 129(4):206).
  • A randomized, double-blind study on IFT therapy after knee surgery, with IFT self-administered at home, found statistically significant improvement on pain scores, edema, range of motion and decreased use of pain medication (Clin J of Sport Medicine (2003) 13:16).
  • A randomized, double-blind trial, studying self-administered NMES for back pain, found that NMES treatment was associated with almost twice the pain relief of placebo (p<0.001, Arch Phys Med Rehabil. 1997 Jan;78(1):55).
  • A 2001 randomized, double-blind trial assessing NMES as an adjunct to exercise for non-acute low back pain found significantly improved lumbar spine function with NMES (Journal of Pain 2(5):295).


Would you like to talk about a product? Please contact us at 866.712.0881